Goldfinch Bio is a biotechnology company that develops and commercializes gene therapies for the treatment of kidney diseases.
Business Model:
Revenue: $3M
Employees: 51-200
Address: 215 First Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Goldfinch Bio is a biotechnology company that develops and commercializes gene therapies for the treatment of kidney diseases.
Contact Phone:
+16173374200
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | Series B | 9 | $100M |
Ally Bridge Group BlackRock Casdin Capital Eventide Gilead Sciences Irving Investors Regent Capital Schroder Adveq Wellington Management Ally Bridge Group BlackRock Casdin Capital Eventide Gilead Sciences Irving Investors Regent Capital Schroder Adveq Wellington Management |
11/2016 | Seed | $596 | 5/2019 | Corporate Round | 1 | $55M |
Gilead Sciences Gilead Sciences |
12/2016 | Series A | 1 | $55M |
Third Rock Ventures Third Rock Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|